Kei Ishibashi
- Immunology top 5%
- Pulmonary and Respiratory Medicine top 5%
- Oncology top 10%
- Molecular Biology
- Urology top 1%
- Co-authors
- Nobuhiro HagaYoshiyuki KojimaKen AikawaKensuke OikawaTomohiko YanagidaMasahiro KitadaHiroya KobayashiTatsuo Suzutani
- Topics
- Urinary Bladder and Prostate Research (23 papers)Prostate Cancer Diagnosis and Treatment (19 papers)Pelvic floor disorders treatments (15 papers)
- Cited by
- UrologyImmunologyRheumatology
- Journals
- New England Journal of MedicineThe Journal of Experimental MedicineSHILAP Revista de lepidopterología
- Partner nations
- JapanUnited StatesChina
In The Last Decade
Kei Ishibashi
103 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 101
- Immunology 479
- Pulmonary and Respiratory Medicine 466
- Oncology 453
- Molecular Biology 328
- Urology 319
Countries citing papers authored by Kei Ishibashi
This map shows the geographic impact of Kei Ishibashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kei Ishibashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kei Ishibashi more than expected).
Fields of papers citing papers by Kei Ishibashi
This network shows the impact of papers produced by Kei Ishibashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kei Ishibashi. The network helps show where Kei Ishibashi may publish in the future.
Co-authorship network of co-authors of Kei Ishibashi
This figure shows the co-authorship network connecting the top 25 collaborators of Kei Ishibashi. A scholar is included among the top collaborators of Kei Ishibashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kei Ishibashi. Kei Ishibashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 8 | |
| 4 | 44 | |
| 5 | 12 | |
| 6 | 3 | |
| 7 | 8 | |
| 8 | 11 | |
| 9 | 7 | |
| 10 | 28 | |
| 11 | 7 | |
| 12 | Prostatic Adenocarcinoma With Pseudocapsule | 1 |
| 13 | 31 | |
| 14 | 17 | |
| 15 | 9 | |
| 16 | 9 | |
| 17 | 36 | |
| 18 | 37 | |
| 19 | 5 | |
| 20 | 1 |
About Kei Ishibashi
Kei Ishibashi is a scholar working on Urology, Rheumatology and Pulmonary and Respiratory Medicine, having authored 106 papers that have together received 1.6k indexed citations. Recurring topics across this work include Urinary Bladder and Prostate Research (23 papers), Prostate Cancer Diagnosis and Treatment (19 papers) and Pelvic floor disorders treatments (15 papers). The work is most often cited by research in Urology (319 citations), Immunology (479 citations) and Rheumatology (277 citations). Kei Ishibashi has collaborated with scholars based in Japan, United States and China. Frequent co-authors include Nobuhiro Haga, Yoshiyuki Kojima, Ken Aikawa, Kensuke Oikawa, Tomohiko Yanagida, Masahiro Kitada, Hiroya Kobayashi, Tatsuo Suzutani, Yasuaki Harabuchi and Naoko Aoki. Their work appears in journals such as New England Journal of Medicine, The Journal of Experimental Medicine and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.